Depression and health-related quality of life in patients with rheumatoid arthritis

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 5, Issue 5, 2005, Pages 645-653

  Nichol, Michael B ^a   Zhang, Lihua ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Depression; Health related quality of life; Management; Rheumatoid arthritis

Indexed keywords

ANTIDEPRESSANT AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COST OF ILLNESS; DEPRESSION; DISTRESS SYNDROME; HEALTH CARE COST; HEALTH STATUS; HUMAN; INCIDENCE; MANAGED CARE; MEDICAL ASSESSMENT; META ANALYSIS; METHODOLOGY; PATIENT CARE; PATIENT EDUCATION; PHYSICIAN; PREDICTION; PREVALENCE; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; RHEUMATOID ARTHRITIS; SCREENING TEST; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WELLBEING;

EID: 27744550806     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.5.5.645     Document Type: Review

References (71)

1. Pocock SJ. A perspective on the role of quality-of-life assessment in clinical trials. Control. Clin. Trials 12(4 Suppl.), S257-S265 (1991).
2. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 46(2), 328-346 (2002).
3. Akil M, Amos RS. ABC of rheumatology. Rheumatoid arthritis-I: clinical features and diagnosis. Br. Med. J. 310(6979), 587-590 (1995).
4. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22(2 Suppl.), 1-12 (2004).
5. Lawrence RC, Helmick CG, Arnett FC et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41(5), 778-799 (1998).
6. Blumenauer B, Cranney A, Clinch J, Tugwell P. Quality of life in patients with rheumatoid arthritis: which drugs might make a difference? PharmacoEconomics 21(13), 927-940 (2003).
7. Alacron GS. Epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21(3), 589-604 (1995).
8. Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 39(1), 28-33 (2000).
9. Allaire SH, Prashker MJ, Meenan RF. The costs of rheumatoid arthritis. PharmacoEconomics 6(6), 513-522 (1994).
10. Lubeck DP. A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 19(8), 811-818 (2001).
11. Persson LO, Berglund K, Sahlberg D. Psychological factors in chronic rheumatic diseases-a review. The case of rheumatoid arthritis, current research and some problems. Scand. J. Rheumatol. 28(3), 137-144 (1999).
12. Wolfe F. Psychological distress and rheumatic disease. Scand. J. Rheumatol. 28(3), 131-136 (1999).
13. Dickens C, Creed F. The burden of depression in patients with rheumatoid arthritis. Rheumatology (Oxford) 40(12), 1327-1330 (2001).
14. Abdel-Nasser AM, Abd El-Azim S, Taal E, El-Badawy SA, Rasker JJ, Valkenburg HA. Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br. J. Rheumatol. 37(4), 391-397 (1998).
15. Waltz M, Kriegel W, van't Pad Bosch P. The social environment and health in rheumatoid arthritis: marital quality predicts individual variability in pain severity. Arthritis Care Res. 11(5), 356-374 (1998).
16. Doeglas DM, Suurmeijer TP, van den Heuvel WJ et al. Functional ability, social support, and depression in rheumatoid arthritis. Qual. Life Res. 13(6), 1053-1065 (2004).
17. Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J. Rheumatol. 20(5), 790-796 (1993).
18. Magni G, Moreschi C, Rigatti-Luchini S, Merskey H. Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain 56(3), 289-297 (1994).
19. Dickens C, Jackson J, Tomenson B, Hay E, Creed F. Association of depression and rheumatoid arthritis. Psychosomatics 44(3), 209-215 (2003).
20. Evers AW, Kraaimaat FW, Geenen R, Jacobs JW, Bijlsma JW. Longterm predictors of anxiety and depressed mood in early rheumatoid arthritis: a 3 and 5 year follow-up. J. Rheumatol. 29(11), 2327-2336 (2002).
21. Vali FM, Walkup J. Combined medical and psychological symptoms: impact on disability and healthcare utilization of patients with arthritis. Med. Care 36(7), 1073-1084 (1998).
22. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160(14), 2101-2107 (2000).
23. Listing J, Alten R, Brauer D et al. Importance of psychological well being and disease activity in termination of an initial DMARD therapy. J. Rheumatol. 24, 2097-2105 (1997).
24. Bendtsen P, Akerlind I, Hornquist JO. Assessment of quality of life in rheumatoid arthritis: methods and implications. PharmacoEconomics 5(4), 286-298 (1994).
25. Lubeck DP. Patient-reported outcomes and their role in the assessment of rheumatoid arthritis. PharmacoEconomics 22(1 Suppl.), 27-38 (2004).
26. Talamo J, Frater A, Gallivan S, Young A. Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Br. J. Rheumatol. 36 (4), 463-469 (1997).
27. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum. 43(7), 1478-1487 (2000).
28. Ware JE Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study. JAMA 276(13), 1039-1047 (1996).
29. Mathias SD, Colwell HH, Miller DP, Moreland LW, Buatti M, Wanke L. Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Clin. Ther. 22(1), 128-139 (2000).
30. Strand V, Scott DL, Emery P et al. Leflunomide Rheumatoid Arthritis Investigators Groups. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J. Rheumatol. 32(4), 590-601 (2005).
31. Durez P. Nzeusseu Toukap A, Lauwerys BR et al. A randomised comparative study of the short-term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Ann. Rheum. Dis. 63(9), 1069-1074 (2004).
32. Zhao SZ, Fiechtner JI, Tindall EA et al. Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib. Arthritis Care Res. 13(2), 112-121 (2000).
33. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J. Epidemiol. Community Health 34(4), 281-286 (1980).
34. Sivas F, Ercin O, Tanyolac O, Barca N, Aydog S, Ozoran K. The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables. Rheumatol. Int. 24(4), 203-206 (2004).
35. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199-208 (1990).
36. Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H. Validity of EuroQol-a generic health status instrument-in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br. J. Rheumatol. 33(7), 655-662 (1994).
37. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br. J. Rheumatol. 36(5), 551-559 (1997).
38. Wolfe F, Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br. J. Rheumatol. 36(7), 786-793 (1997).
39. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The sickness impact profile: validation of a health status measure. Med. Care 14(1), 57-67 (1976).
40. Sullivan M, Ahlmen M, Bjelle A. Health status assessment in rheumatoid arthritis. I. Further work on the validity of the sickness impact profile. J. Rheumatol. 17(4), 439-447 (1990).
41. Sullivan M, Ahlmen M, Bjella A et al. Health status assessment in rheumatoid arthritis: II. Evaluation of a modified Shorter Sickness Impact Profile. J. Rheumatol. 20, 1500-1507 (1993).
42. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum. 23(2), 146-152 (1980).
43. Salaffi F, Stancati A, Carotti M. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis. Clin. Rheumatol. 21(6), 478-487 (2002).
44. Guillemin F. Functional disability and quality-of-life assessment in clinical practice. Rheumatology (Oxford) 39(Suppl. 1), 17-23 (2000).
45. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A. A generic health status instrument in the assessment of rheumatoid arthritis. Br. J. Rheumatol. 31(2), 87-90 (1992).
46. de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br. J. Rheumatol. 36(8), 878-883 (1997).
47. Quinn MA, Conaghan PG, O'Connor PJ et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 52(1), 27-35 (2005).
48. Ware JE Jr, Keller SD, Hatoum HT et al. The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algorithms. Med. Care 37(5 Suppl.), MS40-MS50 (1999).
49. Verhoeven AC, Boers M, van der Liden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. J. Rheumatol. 27(12), 2801-2809 (2000).
50. Nichol MB, Harada AS. Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. PharmacoEconomics 16(5 Pt 1), 433-448 (1999).
51. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 27(5), 1066-1070 (2004).
52. Fossa SD, Dahl AA. Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer. J. Psychosom. Res. 52(2), 79-87 (2002).
53. Vazquez I, Valderrabano F, Fort J et al. Spanish Co-operative Renal Patients Quality of Life Study Group. Psychosocial factors and health-related quality of life in hemodialysis patients. Qual. Life Res. 14(1), 179-190 (2005).
54. Escalante A, del Rincon I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum. 42(8), 1712-1721 (1999).
55. Mikuls T, Saag K, Criswell L, Merlino L, Cerhan JR. Health related quality of life in women with elderly onset rheumatoid arthritis. J. Rheumatol 30(5), 952-957 (2003).
56. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum. 51(4), 578-585 (2004).
57. Murphy H, Dickens C, Creed F, Bernstein R. Depression, illness perception and coping in rheumatoid arthritis. J. Psychosom. Res. 46(2), 155-164 (1999).
58. Hawley DJ. Psycho-educational interventions in the treatment of arthritis. Baillieres Clin. Rheumatol. 9(4), 803-823 (1995).
59. Riemsma RP, Taal E, Kirwan JR, Rasker JJ. Systematic review of rheumatoid arthritis patient education. Arthritis Rheum. 51(6), 1045-1059 (2004).
60. Brady TJ, Kruger J, Helmick CG, Callahan LF, Boutaugh ML. Intervention programs for arthritis and other rheumatic diseases. Health Educ. Behav. 30(1), 44-63 (2003).
61. Mullen PD, Laville EA, Biddle AK, Lorig K. Efficacy of psychoeducational interventions on pain, depression, and disability in people with arthritis: a meta-analysis. J. Rheumatol. 14(Suppl. 15), 33-39 (1987).
62. Riemsma RP, Kirwan JR, Taal E, Rasker JJ. Patient education for adults with rheumatoid arthritis. Cochrane Database Syst. Rev. (2), CD003688 (2003).
63. Sharpe L, Sensky T, Timberlake N, Ryan B, Brewin CR, Allard S. A blind, randomized, controlled trial of cognitive-behavioural intervention for patients with recent onset rheumatoid arthritis: preventing psychological and physical morbidity. Pain 89(2-3), 275-283 (2001).
64. Sharpe L, Sensky T, Timberlake N, Ryan B, Allard S. Long-term efficacy of a cognitive behavioural treatment from a randomized controlled trial for patients recently diagnosed with rheumatoid arthritis. Rheumarology (Oxford) 42(3), 435-441 (2003).
65. Evers AW, Kraaimaat FW, van Riel PL, de Jong AJ. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 100(1-2), 141-153 (2002).
66. Ash G, Dickens CM, Creed FH, Jayson MI, Tomenson B. The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology (Oxford) 38(10), 959-967 (1999).
67. Bird H, Broggini M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double-blind, parallel group study. J. Rheumatol. 27(12), 2791-2797 (2000).
68. Frank RG, Kashani JH, Parker JC et al. Antidepressant analgesia in rheumatoid arthritis. J. Rheumatol 15(11), 1632-1638 (1988).
69. Sarzi Puttini P, Cazzola M, Boccassini L et al. A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J. Int. Med. Res. 16(5), 331-337 (1988).
70. Parker JC, Smarr KL, Slaughter JR et al. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum. 49(6), 766-777 (2003).
71. Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum. 42(9), 1797-1808 (1999).